EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Newsroom
Company News
Media Report
Company News
More
2025-03-21
Professor Adrian V. S. Hill FRS from Oxford University Visits CanSinoBIO, Highlights Vaccine Innovations
SPIMACO and CanSinoBIO Sign an Agreement to Localise and Market the MCV4 Vaccine in Saudi Arabia and MENA
2025-03-26
CanSinoBIO Obtained Approval for Clinical Trials on DTcP-Hib-MCV4 Combined Vaccine
2025-02-24
CanSinoBIO Announces Priority Review Status for DTcP Infant
2025-02-07
CanSinoBIO Obtained Halal Decree of Menhycia® in Indonesia
2025-02-06
CanSinoBIO Received Acceptance of New Drug Application for its Tetanus Vaccine
2025-02-06
Media Report
More
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Time：2025-03-28
More
CanSinoBIO to Showcase China’s Vaccine Innovation at 2025 World Government Summit in Dubai
Time：2025-02-14
More
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
Time：2024-10-09
Source：ACN Newswire
More
津公网安备12011602300399
